Smartest Doc
Trends in chronic kidney disease Full Text
U.S. Pharmacist,
In 2008, it cost about $40 billion to treat more than 500,000 adult ESRD patients with diabetes (37.5%), hypertension, (24.4%), glomerulonephritis (15.2%), or cystic kidney (4.8%) as the primary underlying disease. Of the 70% of ESRD patients who had dialysis, 91.7% and 1% received in–center and home hemodialysis, respectively. Of the remaining patients (26,546 cases), 63.5% and 36.3%, respectively, were administered continuous cycler–assisted and continuous ambulatory peritoneal dialysis.
